United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz

Credit: Mondaq- Published on March 4, 2024
The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to negotiate prices...

You are here

Related news from verified sources

On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price...
on March 4, 2024 • Mondaq

Our team's preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024.
on March 4, 2024 • Mondaq

You might like